The Ultrahuman M2 Live health platform is a new health subscription that doesn't require a prescription to offer users access to continuous glucose monitoring (CGM). The service aims to make CGM more accessible and easy to use than ever before, and works with the Abbott Lingo to provide metabolic insights by tapping into the readings from the wearable. The service is priced at $99 per month and will work without an Ultrahuman device, but will reportedly provide even deeper insights and health data access with the Ultrahuman Ring in the mix.
The Ultrahuman M2 Live health platform will provide users with a Metabolic Score that ranges from 0 to 100 alongside a Food Score with the same range, and glucose tracking and spike detection.
Prescription-Free Glucose Monitoring Services
Ultrahuman M2 Live Offers Metabolic Insights
Trend Themes
-
Prescription-free Monitoring — Consumer access to clinical-grade glucose data is shifting diagnostics toward self-directed health services that reduce reliance on traditional gatekeepers.
-
Metabolic Intelligence Subscriptions — Monthly platforms that translate biomarker readings into scores and insights create recurring revenue models around personalized nutrition and wellness.
-
Wearable Data Fusion — Combining CGM signals with smart ring metrics enables richer health profiles that differentiate connected wellness ecosystems through layered biometric context.
Industry Implications
-
Digital Health — App-based metabolic tracking expands the market for remote preventive care by blending medical-style monitoring with consumer-friendly software experiences.
-
Wearable Technology — Sensor ecosystems gain new value when devices interoperate across glucose, sleep, activity, and recovery data to support more holistic health interpretation.
-
Nutrition Services — Real-time food scoring connects dietary behavior with immediate glucose feedback, opening space for personalized coaching, meal planning, and functional food partnerships.